Volume | 50 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Altimmune Inc | ALT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.37 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
1 | 50 | - | 3.83 - 23.49 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
04:29:06 | 50 | $ 4.50 | USD |
Altimmune Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 215.35M | 49.28M | 42.96M | $ -68.00k | $ - | -1.78 | 3.80 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 953.42k | 10.30% |
Altimmune News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.25 | 4.97 | 4.14 | 4.43 | 2,873,216 | 0.12 | 2.82% |
1 Month | 12.00 | 12.145 | 4.14 | 6.55 | 3,033,365 | -7.63 | -63.58% |
3 Months | 14.71 | 17.17 | 4.14 | 9.58 | 1,848,473 | -10.34 | -70.29% |
6 Months | 12.64 | 17.17 | 4.14 | 10.58 | 1,589,493 | -8.27 | -65.43% |
1 Year | 6.30 | 23.49 | 3.83 | 11.63 | 1,739,124 | -1.93 | -30.63% |
3 Years | 3.04 | 35.10 | 2.80 | 13.24 | 1,840,316 | 1.33 | 43.75% |
5 Years | 1.19 | 36.25 | 0.245 | 11.00 | 1,423,634 | 3.18 | 267.23% |
Altimmune Description
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines. |